SUBSCRIBE
SUBSCRIBE
News   Business

InvestBio Injects $6 Million In The Vaccine Company LP’s Series C

May 9, 2006 | 
1 min read
5/9/2006 – The Vaccine Company LP, which is focused on mutations of the myeloid cell line, said that it has raised the remaining $6 million of its $20 million Series C round.

Startups
MORE ON THIS TOPIC
Rainy season, heavy rain, Rain drops background, Nature rainfall with storm clouds
Earnings
Daiichi takes $850M charge, axes facility investment as ADC demand forecast falls
May 11, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Indianapolis, U.S. - April 16, 2016: Eli Lilly and Company World Headquarters. Lilly makes Medicines and Pharmaceuticals VI
Manufacturing
Lilly invests $4.5B in Indiana manufacturing, opens doors of 1st genetic medicine site
May 8, 2026
 · 
1 min read
 · 
Gabrielle Masson
IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch
IPO tracker
Odyssey launches upsized $279M IPO, Seaport docks on Nasdaq
May 8, 2026
 · 
12 min read
 · 
Editorial Team
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Gilead laying off vast majority of Arcellx employees
May 8, 2026
 · 
51 min read
 · 
BioSpace Editorial Staff